Skip to main content
NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.92
-0.04 (-0.45%)
At close: Mar 9, 2026, 4:00 PM EDT
8.75
-0.17 (-1.91%)
After-hours: Mar 9, 2026, 6:48 PM EDT

NeoGenomics Revenue

In the year 2025, NeoGenomics had annual revenue of $727.33M with 10.11% growth. NeoGenomics had revenue of $190.17M in the quarter ending December 31, 2025, with 10.56% growth.

Revenue (ttm)
$727.33M
Revenue Growth
+10.11%
P/S Ratio
1.59
Revenue / Employee
$290,933
Employees
2,500
Market Cap
1.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025727.33M66.77M10.11%
Dec 31, 2024660.57M68.92M11.65%
Dec 31, 2023591.64M81.92M16.07%
Dec 31, 2022509.73M25.40M5.24%
Dec 31, 2021484.33M39.88M8.97%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Neogen 880.32M
Myriad Genetics 824.50M
OPKO Health 606.88M
Veracyte 517.15M
GeneDx Holdings 427.54M
Twist Bioscience 391.56M
CareDx 379.81M
Castle Biosciences 344.23M
Revenue Rankings

NEO News

More News